Figure 2.
Comparative efficacy of different interventions for failing to induce remission in patients with mild-moderate ulcerative colitis against (A) placebo and (B) standard-dose (2–3g/d) mesalamine, based on network meta-analysis
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.